Cost of pancreatic cancer care reduced by the introduction of new medicines, study suggests

Written by Georgia Cousins

Results from a preliminary health economic outcomes study suggest that the introduction and use of more effective prescription drug therapies is having such a great therapeutic benefit, it is actually driving a decrease in the total cost of healthcare for pancreatic cancer patients. Pancreatic cancer has one of the lowest survival rates among the different cancer types; there is still a great unmet need for treatment options for pancreatic cancer patients. Research into new and effective therapeutics is ongoing, but at what cost? In this study, researchers carrying out a health economic outcomes study at the Virginia Mason Medical Center...

To view this content, please register now for access

It's completely free